[SY1] シンポジウム1「認知症治療薬の最新動向」

[SY1-4] Brainshuttle™ AD - a Phase Ib/IIa study of trontinemab in people with Alzheimer’s disease

^○Luka Kulic¹, Fabien Alcaraz¹, Carsten Hofmann¹, Denise Sickert¹, Maddalena Marchesi¹, Jakub Wojtowicz¹, Gregory Klein¹, Ruth Croney¹, David Agnew¹, João Abrantes¹, Silke Ahlers², Paul Delmar¹, Iris Wiesel¹ (1.F. Hoffmann-La Roche Ltd., 2.Excelya Germany GmbH)